Predicting treatment outcomes in drug-sensitive pulmonary tuberculosis patients in rural eastern China

Tian Tian1, Jia-Wang Lu2, Ting Jiang2

  • 1Department of Infectious Diseases, Affiliated Rudong Hospital of Xinglin College, Nantong University, Nantong, China.

BMC Infectious Diseases
|September 30, 2025
PubMed
Abstract

Insights

A new prediction model identifies key risk factors for unsuccessful pulmonary tuberculosis (PTB) treatment in rural China. This tool helps clinicians identify high-risk patients for tailored interventions and improve TB control.

Area of Science:

  • Public Health
  • Epidemiology
  • Clinical Medicine

Background:

  • Pulmonary tuberculosis (PTB) remains a significant public health challenge, particularly in rural areas of China.
  • Identifying factors contributing to unsuccessful treatment is crucial for improving patient outcomes and disease control.
  • Drug-sensitive PTB treatment success is influenced by various patient and disease-related factors.

Purpose of the Study:

  • To identify risk factors for unsuccessful treatment outcomes in newly diagnosed, drug-sensitive PTB patients in rural eastern China.
  • To develop and validate a prediction model for identifying patients at high risk of treatment failure.
  • To assess the clinical utility of the developed prediction model for guiding interventions.

Main Methods:

  • Analysis of 838 newly diagnosed drug-sensitive PTB patients in rural eastern China (2021-2023).
  • Multivariate logistic regression to identify predictors of unsuccessful treatment outcomes.
  • Internal validation using a training (70%) and validation (30%) set; Decision Curve Analysis (DCA) for clinical utility assessment.

Main Results:

  • Six independent predictors of unsuccessful PTB treatment were identified: diabetes, chronic lung disease, alcohol use, hypoalbuminemia, anemia, and sputum smear grades.
  • The prediction model demonstrated good discriminative ability with an AUC of 0.754.
  • A nomogram and online calculator were developed for practical clinical application, showing significant net benefit via DCA.

Conclusions:

  • A validated prediction model can effectively identify high-risk PTB patients in rural eastern China.
  • The model facilitates tailored interventions, potentially enhancing treatment strategies and TB control efforts.
  • This tool supports clinicians in making informed decisions for better PTB management.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
540
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
478
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
937
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
838